ST-segment displacement in Duchenne muscular dystrophy: Myocardial necrosis or apoptosis?

Acta Myologica

Volumn 22, Issue MAY, 2003, Pages 5-10

  Politano, Luisa ^a   Palladino, A ^b   Petretta, V R ^b   Mansi, L ^b   Passamano, L ^b   Nigro, Ge ^a   Comi, L I ^b   Nigro, G ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b I Policlinico ^*

Author keywords

Apoptosis; Duchenne muscular dystrophy; Dystrophic cardiomyopathy; Pseudo infarction

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKER; FOSINOPRIL; GLUCOSE; HEPARIN; INSULIN; POTASSIUM; UBIQUINONE;

APOPTOSIS; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; DYSPNEA; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HUMAN; MALE; Q WAVE; QT INTERVAL; ST SEGMENT ELEVATION; SWEATING; SYMPTOMATOLOGY; THORAX PAIN;

APOPTOSIS; CARDIOMYOPATHIES; CHILD; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL INFARCTION; NECROSIS;

EID: 0042090701     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nigro G, Comi LI, Politano L, et al. Electrocardiographic evaluation of the P type stage of dystrophic cardiomyopathy. Cardiomyology 1984;III:45-58.
2. Comi LI, Politano L, Petretta VR, et al. PQ interval in dystrophinopathic cardiac involvement. Acta Cardiomiologica 1993;12:127-32.
3. Nigro G, Comi LI, Politano L, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle & Nerve 1995;18:283-91.
4. Towbin JA, Bricker JT, Garson A jr. Electrocardiographic criteria for diagnosis of acute myocardial infarction in childhood. Am J Cardiol 1992;69:1545-8.
5. Nigro G, Comi LI, Politano L, Bain RHJ. The incidence and evolution of cardiomyopathy in Duchenne Muscular Dystrophy. Intern J Cardiol 1990;26:271-7.
6. Nigro G, Politano L, Nigro V, et al. Mutation of dystrophin gene and cardiomyopathy. Neuromusc Disord 1994;4:371-9.
7. Comi LI, Nigro G, Politano L, et al. Treatment of dystrophic cardiomyopathy. Acta Cardiomiol 1991;10:351-6.
8. Nigro G, Comi LI, Politano L, Nigro V. Dilated cardiomyopathy of muscular dystrophy: a multifaceted approach to management. Sem Neurol 1995;15:90-2.
9. Ravkilde J, Nissen H, Horder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995;25:574-81.
10. Wu AHB, Feng YJ. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 1998;19:N25-9.
11. Riga PJ, Shenenberger DW. Diagnostic and prognostic role of cardiac troponins. J Intern Med 2003;253:50.
12. Takagi T, Shimada Y. Progressive muscular dystrophy with electrocardiographic findings of myocardial infarction. Naika 1970;26:764-9.
13. Fiorista F, Brambilla G, Saviotti M, et al. Myocardial infarction in a child aged ten with Duchenne muscular dystrophy. Z Kardiol 1981;70:784-8.
14. Cuccia C, Benedini G, Leonzi O, et al. Acute myocardial infarction in a 13-year-old boy with Duchenne's disease. G Ital Cardiol 1984;14:817-20.
15. Witkowski C. Myocardial infarction in a patient with progressive muscular dystrophy. Przegl Lek 1987;44:359-60.
16. Ellis RE, Yuan J, Horvitz HR. Mechanism and functions of cell death. Annu Rev Cell Biol 1991;7:363-98.
17. Majno G, Joris I. Apoptosis, oncosis, necrosis: an overview of cell death. Am J Pathol 1995;146:3-15.
18. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Apoptosis: the molecular basis of cell death. Tomei LD, Cope FO editors, New York: Cold Spring Harbor Laboratory Press; 1991;5-29.
19. Adhyhetty PJ, Hood DA. Mechanism of apoptosis in skeletal muscle. Basic Appl Myol 2003;13:171-9.
20. Primeau AJ, Adhihetty PJ, Hood DA. Apoptosis in heart and skeletal muscle. Can J Appl Physiol 2002;27:349-95.
21. Elsasser A, Suzuki K, Schaper J. Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure. J Mol Cell Cardiol 2000;32:711-24.
22. Narula J, Kolodgie FD, Virmani R. Apoptosis and cardiomyopathy. Curr Opin Cardiol 2000;15:183-8.
23. Valen G. The basic biology of apoptosis and its implication for cardiac function and viability. Ann Thorac Surg 2003;75:655-60.
24. Clerk A, Cole SM, Cullingford TE, et al. Regulation of cardiac myocyte cell death. Pharmacol Ther 2003;97:223-61.
25. Umansky SR, Tomei LD. Apoptosis in the myocardium: much is still expected. Expert Opin Ther Targets 2003;7:61-9.
26. Haider N, Narula N, Narula J. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J Card Fail 2002;8:512-7.
27. Chen YJ, Wu R, Huang XH. Cardiac death and apoptosis of myocardium. Fa Yi Xue Za Zhi 1999;15:133-4.
28. van den Eijnde SM, Luijsterburg AJ, Boshart L, et al. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry 1997;29:313-20.
29. Narula J, Zaret BL. Non-invasive detection of cell death: from tracking epitaphs to counting coffins. J Nucl Cardiol 2002;9:554-60.
30. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med 2003;30:615-30.